Buy or sell Ablative Solutions stock pre IPO via an EquityZen fund
Ablative Solutions Stock
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
About Ablative Solutions Stock
Ablative Solutions, Inc., was founded in 2011 by Tim Fischell, MD, FACC, and David Fischell, PhD, to address this significant unmet medical need. Ablative Solutions’ technology involves endovascular catheters to provide an efficacious, durable, cost-effective and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.
David R. Fischell
CEO & CMO, Board of Directors
President & COO, Board of Directors
Forbes - Feb, 5 2019